Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Merck Serono and Pharmaron Partner in Beijing Lab

publication date: Sep 14, 2011
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Merck Serono, the biopharma division of Germany’s Merck KGaA, announced a strategic partnership with Pharmaron, the US-China CRO. Pharmaron has opened a new Beijing facility that will be Merck Serono’s China R&D lab. It will be tasked with developing new drugs for cancer and neurodegenerative diseases. Pharmaron is supplying Merck Serono with staff, as well as the physical facilities. More details....

Stock Symbol: (XE: MRK)     Share this with colleagues:  

 


This article is available for purchase - please click here for details.


Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Alibaba IPO
Event Updates
Greg Scott will be attending and speaking at this event:
 
 
Hope to see you there!
 
ChinaBio® Events
 
China Forum 2014

Frankfurt, Germany
November 2, 2014

>> More events...

Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors